Journal of Pharmaceutical Policy and Practice

Journal of Pharmaceutical Policy and Practice 由 Springer Nature 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Pharmaceutical Economics and Policy、Pharmaceutical Practices and Patient Outcomes、Antibiotic Use and Resistance 等主题的论文，这 3 个主题约占 44.2%。（根据 OpenAlex 主题统计与中科院分区数据生成）

Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) is an Open Access peer-reviewed journal that provides a platform for researchers to disseminate empirical research findings with the aim that people everywhere have access to the medicines they need and be able to use them rationally. The journal encompasses all aspects of pharmacy, including clinical, social, administration, and economics. It also covers pharmaceutical aspects of healthcare policy, providing a platform to researchers, academics and practitioners from around the world to share evidence, concerns and perspectives on pharmacy systems, management, ethics, and financial analysis. Journal of Pharmaceutical Policy and Practice welcomes for consideration the following types of article: Research Article, Review, Discussion, Comment, Policy Analysis, Short Report, Study Protocol and Article Commentary. All articles received by the journal will be subject to double-anonymous peer review. Journal History In December 2008, Southern Med Review was started by Prof. Zaheer Babar to promote pharmaceutical policy research at a global level. The journal has been unique in publishing the work of new researchers, documenting the pharmaceutical situation of low- and middle-income countries and debating pertinent pharmaceutical policy questions. The journal's work has been recognized at a global level and, according to WHO, it fulfilled a global need. The journal is indexed in Scopus, EMBASE and PubMed Central and in 2013 was relaunched under its new title, Journal of Pharmaceutical Policy and Practice. Archival content An electronic archive of content under the journal's previous name Southern Med Review Volumes 2-5 (2009-2012) can be found on PubMed Central. About the Editor Professor Zaheer-Ud-Din Babar is a Professor of Clinical Pharmacy and Practice at College of Pharmacy, Qatar University,and a Visiting Professor in the Department of Pharmacy at the University of Huddersfield, United Kingdom. He has held several senior academic leadership roles, including Professor of Medicines and Healthcare and Director of the Pharmaceutical Policy and Practice Research Centre at the University of Huddersfield (2017–2023), and Head of Pharmacy Practice at the University of Auckland, New Zealand (2007–2016). He is internationally recognised for his work in pharmaceutical policy and practice, particularly in the quality use of medicines, clinical pharmacy practice, equitable access to me

摘自期刊官网 Aims & Scope

研究方向（LetPub）：Health Professions-Pharmacy

主编 Zaheer-Ud-Din Babar出版商官网

编委会国家分布：中国大陆 2 位（约 3%）；主要国家 美国 8、英国 7、新西兰 5、巴基斯坦 5、卡塔尔 5（共 60 位编委标注了国家） 编委会 ↗出版商官网 · 2026-10-01

中科院期刊分区表

期刊官网公布的 JCR / CiteScore 分区

• JCR Q2 · 最佳分区 · 2025 年度
• CiteScore Q1 · 2025 年度

出版商自述数据，JCR 以 Clarivate、CiteScore 以 Scopus 公布为准；与中科院分区是不同体系。出版商官网

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

PMCEmbaseCASCAB Abstracts出版商官网

其他：Google Scholar、EBSCO、ProQuest、Dimensions、Naver、OCLC、BFI List、CNKI、EBSCO Academic Search、EBSCO Discovery Service、Gale、International Pharmaceutical Abstracts、National Library of New Zealand、OCLC WorldCat Discovery Service、ProQuest Central、ProQuest Health & Medical Collection、ProQuest Nursing & Allied Health Database、ProQuest Pharma Collection、ProQuest-Ex Libris Primo、ProQuest-Ex Libris Summon、Reaxys、SCImago、TD Net Discovery Service、UGC-CARE List (India)、WHO's Essential Medicines Documentation Database

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子（出版商公布） 2025

2.6出版商官网 · 2026-10-01

五年影响因子（出版商公布） 2025

3.2出版商官网 · 2026-10-01

CiteScore 2026-06

4.4LetPub · 2026-09-13

CiteScore（出版商公布） 2025

4.4出版商官网 · 2026-10-01

SJR 2026-06

0.74LetPub · 2026-09-13

SJR（出版商公布） 2025

0.74出版商官网 · 2026-10-01

SNIP 2026-06

1.19LetPub · 2026-09-13

SNIP（出版商公布） 2025

1.19出版商官网 · 2026-10-01

h-index

51OpenAlex · 2026-10-01

i10-index

450OpenAlex · 2026-10-01

两年平均被引

3.33OpenAlex · 2026-10-01

自引率

3.8%LetPub · 2026-09-13

Gold OA 文章占比

100%LetPub · 2026-09-13

发文规模

年文章数

133LetPub · 2026-09-13

年下载量（出版商公布）

431,000出版商官网 · 2026-10-01

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

14 WeeksLetPub · 2026-09-13

录用率（出版商公布）

38%出版商官网 · 2026-10-01

投稿到首次决定

5 天出版商官网 · 2026-10-01

外审后首次决定

42 天出版商官网 · 2026-10-01

接收到发表

25 天出版商官网 · 2026-10-01

投稿到发表（期刊自报）

约 14 周DOAJ · 2026-10-11

评审方式

双盲同行评审DOAJ

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Springer Nature

出版国家或地区

United Kingdom

出版语言

English

ISSN

2052-3211

官网最新一期

Volume 19, Issue 1（2026 年）

官方链接

• 期刊主页 ↗DOAJ
• 投稿系统 ↗出版商官网
• 作者指南 ↗LetPub
• Aims & Scope ↗LetPub
• 专刊 / 特刊征稿 ↗出版商官网
• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ
• 评审流程 ↗LetPub
• 编委会 ↗LetPub
• 查重政策 ↗DOAJ